E Fund Biotech ETF(03186.HK) Falls 1.36% Intraday to HK$16.700, Turnover Rate 1.40%
NewTimeSpace News: As of 13:13 on April 17, 2026, E Fund Biotech ETF(03186.HK) traded at HK$16.700, down 1.36%. The ETF had a trading volume of 21,000 lots, a turnover rate of 1.40%, an intraday amplitude of 1.60%, and assets under management of approximately HK$25.2787 million.
E Fund Biotech ETF(03186.HK) tracks the Solactive Biotech Select Index. The index selects 100 constituent stocks from biopharmaceutical companies listed in Hong Kong and the United States, widely covering major global innovation hubs including China, the United States, Europe, Israel, Switzerland, and Japan.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- KNT HOLDINGS (01025.HK): Placing of up to 37,873,488 new shares at HKD 0.2 per share under general mandate, net proceeds of approximately HKD 7.25 million for working capital
- FU SHOU YUAN (01448.HK): Gong Hailin proposes conditional voluntary cash partial offer of HKD 0.1 per share for up to 115 million shares, representing approximately 4.96% of issued share capital
- VOYAH AUTO (07489.HK): August deliveries of 13,003 vehicles, cumulative 2026 deliveries up 25% year on year to 102,456 units
- BOSS ZHIPIN-W (02076.HK): Chen Xu steps down as President to become CMO, Zhang Tao appointed rotating President
- C STRATEGIC TEC (01725.HK): Unaudited August revenue of approximately RMB 52.27 million, down 70.97% year on year
